Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys 21,309 Shares of Medtronic PLC $MDT

Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of Medtronic PLC (NYSE:MDT) by 7.3% during the second quarter, HoldingsChannel.com reports. The firm owned 314,551 shares of the medical technology company’s stock after buying an additional 21,309 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Medtronic were worth $27,419,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in MDT. Gilbert & Cook Inc. lifted its holdings in shares of Medtronic by 1.9% in the second quarter. Gilbert & Cook Inc. now owns 6,103 shares of the medical technology company’s stock worth $532,000 after buying an additional 114 shares in the last quarter. Red Spruce Capital LLC increased its holdings in Medtronic by 0.5% during the 2nd quarter. Red Spruce Capital LLC now owns 23,707 shares of the medical technology company’s stock worth $2,067,000 after acquiring an additional 118 shares during the period. Certior Financial Group LLC lifted its stake in Medtronic by 3.7% in the 1st quarter. Certior Financial Group LLC now owns 3,450 shares of the medical technology company’s stock worth $310,000 after purchasing an additional 122 shares in the last quarter. PrairieView Partners LLC lifted its stake in Medtronic by 3.6% in the 2nd quarter. PrairieView Partners LLC now owns 3,726 shares of the medical technology company’s stock worth $324,000 after purchasing an additional 128 shares in the last quarter. Finally, Motco boosted its holdings in Medtronic by 27.0% in the 1st quarter. Motco now owns 635 shares of the medical technology company’s stock valued at $57,000 after purchasing an additional 135 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on MDT shares. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $111.00 price target on shares of Medtronic in a report on Friday, October 10th. Wall Street Zen cut Medtronic from a “buy” rating to a “hold” rating in a research report on Sunday, November 2nd. Citigroup upped their target price on Medtronic from $101.00 to $112.00 and gave the stock a “buy” rating in a research note on Tuesday, October 7th. Truist Financial raised their price target on Medtronic from $96.00 to $103.00 and gave the company a “hold” rating in a report on Wednesday, October 15th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Medtronic in a research report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $103.06.

Medtronic Stock Performance

NYSE MDT opened at $95.92 on Friday. The company has a 50-day simple moving average of $94.43 and a two-hundred day simple moving average of $90.39. The company has a quick ratio of 1.50, a current ratio of 2.01 and a debt-to-equity ratio of 0.54. Medtronic PLC has a 12-month low of $79.29 and a 12-month high of $99.37. The firm has a market cap of $123.04 billion, a price-to-earnings ratio of 26.42, a PEG ratio of 2.42 and a beta of 0.77.

Medtronic (NYSE:MDT) last released its quarterly earnings data on Tuesday, August 19th. The medical technology company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.23 by $0.03. Medtronic had a return on equity of 14.61% and a net margin of 13.63%.The firm had revenue of $8.58 billion for the quarter, compared to the consensus estimate of $8.37 billion. During the same quarter in the previous year, the business earned $1.23 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS. On average, equities analysts forecast that Medtronic PLC will post 5.46 EPS for the current year.

Insider Buying and Selling

In other news, EVP Harry Skip Kiil sold 8,605 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $91.58, for a total value of $788,045.90. Following the transaction, the executive vice president owned 35,615 shares in the company, valued at approximately $3,261,621.70. This trade represents a 19.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William R. Jellison bought 2,500 shares of the firm’s stock in a transaction that occurred on Monday, August 25th. The stock was purchased at an average cost of $92.37 per share, for a total transaction of $230,925.00. Following the completion of the purchase, the director owned 5,000 shares of the company’s stock, valued at $461,850. This trade represents a 100.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.26% of the stock is owned by insiders.

Medtronic Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.